Category: News
Zanos Lab at the European Research Night 2024 in Cyprus
No Comments
| News
We are excited to share that Zanos Lab participated in this year’s European Research Night (ERN) event in Cyprus, an initiative aimed at bringing research and innovation closer to the public. During the event, we had the opportunity to engage with students and visitors, offering insights into our ongoing research projects focused on addiction. Our […]
Our postdoctoral fellow, Dr. Andria Michael, was awarded a Marie Skłodowska-Curie Young Investigator grant (€147.000) for Innovative research in the Zanos lab
We are thrilled to announce that our postdoctoral fellow, Dr. Andria Michael, from the Zanos lab, has been awarded a prestigious Marie Skłodowska-Curie young investigator grant under the ONISILOS co-fund scheme. This grant will support Dr. Michael’s innovative research aimed at identifying the role of Vascular Endothelial Growth Factor A (VEGF-A) in the development of […]
New Publication: Ketamine as a Potential Treatment for Opioid Use Disorder
The Zanos lab is excited to announce the publication of our latest research paper in the prestigious journal Biological Psychiatry. Our study explores the potential of ketamine and its metabolites as novel therapeutic strategies for treating Opioid Use Disorder (OUD). In this comprehensive review, we examine both preclinical and clinical research on ketamine’s potential in […]
New Publication: Unveiling the Links Between Viral Infections and Alzheimer’s Disease
The Bioinformatics Unit of the Zanos Lab is proud to announce our latest publication, “From Viral Infections to Alzheimer’s Disease: Unveiling the Mechanistic Links Through Systems Bioinformatics,” which explores the complex relationship between viral infections and Alzheimer’s disease (AD). Dr. Anna Onisiforou utilized advanced systems bioinformatics techniques to investigate how various viruses, including herpesviruses, hepatitis […]
Our postdoctoral fellow, Dr. Alexis Panutsopulos was awarded a Marie Skłodowska-Curie Young Investigator Grant (€ 147.000) for Innovative Research in the Zanos Lab
We are thrilled to announce that our postdoctoral fellow, Dr. Panutsopulos, has been awarded a Marie Skłodowska-Curie Young Investigator grant under the ONISILOS co-fund scheme. This grant will support Dr. Panoutsopoulos’ cutting-edge research aimed at investigating the role of antidepressants, such as SSRIs and ketamine, in the development of neural tube defects (NTDs) during early […]
Zanos Lab awarded €20,000 grant by the A. G. Leventis Foundation for our ongoing research on rapid-acting antidepressants.
We are excited to announce that the Zanos Lab has just been awarded a grant of €20,000 by the A.G. Leventis Foundation. This funding will significantly enhance our ongoing research efforts to uncover the mechanisms of action behind rapid-acting antidepressant compounds. Depression remains one of the most challenging mental health conditions, and the discovery of […]
New article published in a Cypriot Newspaper by members of the Zanos Lab: Understanding “Smiling” Depression in the Era of Social Media
Researchers from the Zanos Lab have published an article in the Greek newspaper “Neolaia” (Youth) examining the phenomenon of “smiling” depression. This form of depression is characterized by individuals presenting a cheerful, successful image on social media while concealing their true feelings of sadness. The article, co-authored by Dr. Anna Onisiforou and Dr. Panos Zanos, […]
Zanos laboratory’s BioNic research featured in major Cypriot newspaper: Pioneering the future of smoking cessation
The Zanos Laboratory at the University of Cyprus has recently been featured in one of Cyprus’ leading newspapers for its groundbreaking BioNic research program. Led by Principal Investigator Dr. Panos Zanos and Marie Curie fellow Dr. Andrea N. Georgiou, this innovative study aims to revolutionize smoking cessation strategies by identifying biological markers that can predict […]
Groundbreaking Phase I clinical trial results: (2R,6R)-Hydroxynorketamine (HNK) shows excellent safety profile.
We are thrilled to announce a major milestone in our research journey. The manuscript detailing the Phase I clinical trial results for (2R,6R)-Hydroxynorketamine (HNK), a metabolite of ketamine, has just been published. The study, titled “A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-HNK in healthy volunteers,” demonstrates the compound’s excellent […]
Dr. Zanos’s Research Leads the Field in Ketamine Studies for Depression
We are proud to announce that Dr. Zanos’s groundbreaking research on ketamine has achieved exceptional recognition within the scientific community. According to a recent publication in the European Archives of Psychiatry and Clinical Neuroscience, Dr. Zanos’s work constitutes the top three most cited papers on ketamine and its enantiomers for depression from 2000 to 2023. […]